# 22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions

> **NCT06563232** · NA · NOT_YET_RECRUITING · sponsor: **Huazhong University of Science and Technology** · enrollment: 656 (estimated)

## Conditions studied

- Pancreatic Neoplasms
- Mediastinal Neoplasms
- Abdominal Neoplasm, Excluding Pancreas Neoplasm

## Interventions

- **DEVICE:** FNA group
- **DEVICE:** Adapt FNB group

## Key facts

- **NCT ID:** NCT06563232
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 656 (ESTIMATED)
- **Last updated:** 2024-08-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06563232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06563232, "22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT06563232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*